PhRMA at­tacks New Mex­i­co’s ‘short on de­tail’ plan for Cana­di­an drug im­ports

In­dus­try group PhRMA con­tin­ues to fight a Trump-era fi­nal rule to al­low drug im­ports from Cana­da as the lob­by­ing group has now pe­ti­tioned the FDA to re­ject New Mex­i­co’s im­port plan be­cause of miss­ing de­tails that may make the im­port­ed drugs un­safe and not cost-ef­fec­tive.

The ap­pli­ca­tion “pro­vides scant in­di­ca­tion that the pro­posed SIP [Sec­tion 804 Im­por­ta­tion Pro­gram] will lead to any—let alone sig­nif­i­cant—re­duc­tion in cost to con­sumers,” PhRMA said in its pe­ti­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.